Skip to main content
ABVC
NASDAQ Life Sciences

ABVC Slashes Land-Acquisition Share Cap to 1.6M, Discloses Board Member as Seller

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.01
Mkt Cap
$30.535M
52W Low
$0.707
52W High
$3.4
52W Position info
43% above low
Off High info
70% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ABVC sits 43% above its 52-week low of $0.707.

Summary

ABVC's revised proxy cuts the land-acquisition share cap to 1.6M shares and reveals the seller is a Board member holding ~14% of voting power. Appraisals value the Taiwan properties at ~US$622K, payable entirely in stock.


Key Events · Corporate Governance and Compliance · ABVC

  • Land-Acquisition Share Cap Cut to 1.6M

    Maximum issuance for the Taiwan land acquisition reduced from 6.6 million shares to 1,600,653 shares at no less than $1.00 per share.

  • Board Member Identified as Seller

    Ms. Shuling Jiang, a Board member, is the seller and currently owns 3,735,572 shares (~14% voting power). Full issuance would raise her stake to ~18.86%.

  • Appraisals Value Properties at ~US$622K

    Independent appraisals value Taoyuan Lands at NT$10,948,541 (~US$339,048) and Hualien Property at NT$9,146,467 (~US$283,243), totaling NT$20,095,008 (~US$622,291).

  • 2026 Equity Incentive Plan Details

    Award pool set at 1,169,201 shares plus 15% of outstanding on meeting date, with a 5% annual evergreen provision starting 2027.


Analysis · ABVC · Life Sciences

The third proxy amendment from ABVC materially revises the proposed land acquisition: the maximum share issuance drops from 6.6 million to 1,600,653 shares, and the seller is now identified as Board member Shuling Jiang, who already holds ~14% of voting power. Independent appraisals value the Taiwan properties at ~US$622,291, with consideration to be paid entirely in stock at no less than $1.00 per share. Given the related-party nature of the deal and the potential for the seller's ownership to rise to ~18.86%, this is a governance-sensitive transaction that shareholders should scrutinize before the October 8 vote.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ABVC was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.5M. The 52-week trading range was $0.71 to $3.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ABVC - Latest Insights

ABVC
Nov 10, 2026, 6:20 PM EST
Filing Type: S-3/A
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.900 info
Change: -$0.100 (-10%) info
Market Cap: $23.37M info
ABVC
Nov 10, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.900 info
Change: -$0.100 (-10%) info
Market Cap: $23.37M info
ABVC
Nov 02, 2026, 9:51 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.900 info
Change: -$0.1499 (-14%) info
Market Cap: $23.37M info
ABVC
Nov 02, 2026, 9:30 AM EST
Source: EQS
Importance Score:
7
Price at Filing: $1.04
Real-time Price: $0.900 info
Change: -$0.140 (-13%) info
Market Cap: $23.37M info
ABVC
Sep 29, 2026, 12:22 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $0.900 info
Change: -$0.130 (-13%) info
Market Cap: $23.37M info